IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NODARI, Savina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.836
EU - Europa 15.687
AS - Asia 9.616
AF - Africa 54
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 27
AN - Antartide 1
Totale 48.291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.743
UA - Ucraina 5.224
CN - Cina 4.924
IT - Italia 3.329
DE - Germania 2.024
SG - Singapore 1.842
HK - Hong Kong 1.168
FI - Finlandia 1.004
TR - Turchia 800
IN - India 790
IE - Irlanda 789
PL - Polonia 770
GB - Regno Unito 762
RU - Federazione Russa 666
FR - Francia 621
SE - Svezia 310
CA - Canada 83
BE - Belgio 57
MU - Mauritius 41
EU - Europa 31
NL - Olanda 30
VN - Vietnam 26
AU - Australia 24
BR - Brasile 24
CH - Svizzera 20
ES - Italia 16
ID - Indonesia 13
AT - Austria 10
RO - Romania 10
CZ - Repubblica Ceca 9
IR - Iran 9
JP - Giappone 7
TH - Thailandia 7
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
CO - Colombia 4
LT - Lituania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BZ - Belize 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
PE - Perù 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AL - Albania 2
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
UG - Uganda 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HT - Haiti 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 48.291
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.831
Fairfield 1.969
Chandler 1.945
Woodbridge 1.700
Princeton 1.550
Singapore 1.467
Nanjing 1.409
Ann Arbor 1.244
Ashburn 1.220
Wilmington 1.210
Houston 1.172
Hong Kong 1.162
Cambridge 1.035
Dublin 783
Warsaw 751
Seattle 691
Beijing 673
Istanbul 671
New York 602
Nanchang 532
Des Moines 378
Hebei 341
Shenyang 314
Moscow 296
Milan 282
Helsinki 248
Changsha 236
Jiaxing 227
Tianjin 221
San Diego 181
Kunming 177
Rome 169
Dearborn 164
Verona 148
Jinan 134
Brescia 119
Hangzhou 118
Kocaeli 114
Boardman 77
Shanghai 69
Lancaster 65
Ningbo 60
San Francisco 60
Zhengzhou 53
Lanzhou 52
Norwalk 51
Taizhou 49
Changchun 48
Florence 47
Toronto 46
Brussels 44
Naples 39
Napoli 38
Los Angeles 36
London 35
Fuzhou 32
Guangzhou 32
Palermo 32
Catania 29
Pune 29
Haikou 26
Bologna 25
Dong Ket 22
Padova 21
Torino 21
Redwood City 20
Romola 20
Augusta 19
Ottawa 19
Washington 19
San Mateo 17
Westminster 17
Auburn Hills 16
Genoa 16
Orange 16
São Paulo 15
Frankfurt am Main 14
Taiyuan 14
Leawood 13
Trieste 13
Bari 12
Caserta 12
Bergamo 11
Nürnberg 11
Turin 11
Canberra 10
Hefei 10
Monmouth Junction 10
Perugia 10
Pisa 10
Redmond 10
Genova 9
Lappeenranta 9
Messina 9
Modena 9
Pescara 9
Rozzano 9
Santa Clara 9
Cutrofiano 8
Lissone 8
Totale 31.066
Salva come PNG Salva come JPEG
Nome #
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 663
Inodilatatori: perché e quali. 368
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 301
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 290
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 273
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial) 272
Valutazione dell’indice di performance miocardica (MPI) del ventricolo destro con studio eco-doppler in pazienti affetti da insufficienza cardiaca. 266
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 216
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 215
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 210
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 199
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 188
Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. 188
Valvola aortica quadricuspide asintomatica : un caso clinico. 157
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 155
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 154
Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold 153
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 152
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 152
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 148
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 144
Serum levels of different tumoral markers in patients with congestive heart failure. 135
Acute heart failure syndromes: assessment and reconstructing the heart. 134
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 131
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial 126
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 123
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 120
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 119
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 118
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review 118
A rationale for the use of BETA-blockers as standard treatment for heart failure 116
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial 116
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients with Chronic Heart Failure 116
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 114
Beta- adrenergic receptors polymorphisms and response to CRT 114
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial) 114
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 114
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. 112
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 112
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 112
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 111
Clinical significance of Beta-adrenergic receptor polymorphisms in the patients with chronic heart failure 111
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial) 110
Asse cuore-rene nell’iperteso cardiopatico. 109
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 108
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial 108
Anemia and heart failure : a cause of progression or only a consequence? 107
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 105
Abnormal hemodynamics and ventilatory response to exercise may identify chronic heart failure patients at high risk despite long term beta-blocker treatment. 103
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction 103
Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists 103
Rest and exercise effects of the acute and chronic administration of nisoldipine in patients with heart failure. 102
Clinical trials update from the World Congress of Cardiology 2006. 102
Different prognostic values of clinical and metabolic parameters in ischaemic diabetic patients with preserved/impaired left ventricular function. 101
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. 101
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 101
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 100
Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. 100
Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score 100
Influence of the angiotensin-converting enzyme genotype on the response to the beta-blocker therapy and the prognosis of the patients with chronic heart failure. 99
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. 99
A Current treatment in acute and chronic cardio-renal syndrome. 99
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 98
Six-year prognosis of diabetic patients with coronary artery disease. 97
Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. 96
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion 96
Maximal and submaximal exercise testing in heart failure. 96
Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients. 95
Tako-tsubo-like left ventricular dysfunction: transient left ventricular apical ballooning syndrome 95
Response to the letter of Hester Den Ruijter and Ruben Coronel regarding the article "the role of n-3 pufas in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" 95
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events? 95
Ibopamine treatment in dopamine dependent heart failure: purpose of a new treatment scheme. 94
Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function 93
The Prevention of Sudden Death: New Perspectives. 93
Is total arterial myocardial revascularization with composite grafts a safe and useful procedure in the elderly? 93
Redefining biomarkers in heart failure 93
Betabloccanti e sopravvivenza: risultati diversi per farmaci diversi? I risultati dello studio COMET 93
Ruolo prognostico della fibrinogemia in pazienti diabetici ricoverati per sindrome coronarica acuta. 92
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 92
Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure 92
A randomized comparison of the effects of metoprolol and carvedilol on the hemodynamics and functional capacity of patients with heart failure. 91
Weight loss favorably affects the cardiac sympatho-vagal balance of the obese patients: results of power spectral analysis of heart rate variability. 91
Managing heart failure in the very old 91
Role of fluid retention in patients hospitalised for acute heart failure. 91
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 91
Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial 91
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 90
CA 125 Tumoral Marker Plasma Levels Relate to systolic and Diastolic Ventricular Function and to the Clinical Status of Patients with Chronic Heart Failure 90
Beta-1 adrenergic receptor gene polimorphism in heart failure: a gender specific clinical and prognostic role? 90
Acute antianginal efficacy and duration of action of isosorbide 2-mononitrate. 89
The role of beta blockade in heart failure 89
Biventricular cardiac resynchronization in moderate-to-severe heart failure: Analysis of hospital costs and clinical effectiveness (Brescia study) 89
Asymptomatic quadricuspid aortic valve. 89
Clinical significance of beta-adrenergic receptor polymorphisms in the patients with chronic heart failure. 88
Role of worsening renal function in patients hospitalised for acute heart failure 88
Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations. 88
Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies 88
Mediterranean diet impact on cardiovascular diseases: A narrative review 88
Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure. 87
Plasma homocysteine levels and late outcome in patients with unstable angina. 87
Totale 12.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.279 0 0 0 0 0 0 764 1.198 571 1.454 383 909
2020/20218.074 97 1.062 177 989 148 1.054 231 1.058 1.662 521 921 154
2021/20225.011 136 1.082 50 343 85 253 151 371 292 647 523 1.078
2022/20235.509 852 63 48 516 513 1.620 16 565 855 44 194 223
2023/20244.104 333 101 174 234 145 740 121 110 1.207 60 99 780
2024/20253.716 65 57 93 1.249 1.485 762 5 0 0 0 0 0
Totale 48.817